NL-OMON47526已完成4 期
T-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease a prospective randomized trial<br> - Prevention of cardiac events by T2DM patients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Type-2 diabetes mellitus for at least six months
- •>18 years of age men or female
- •written informed consent to participate in the study and ability to comply with
- •all requirements
排除标准
- •maximum dose of RAS-antagonists or beta-blocker
- •symptomatic hypotension and/or systolic blood pressure < 100 mgHG at visit 1
- •symptomatic bradycardia and/or heart rate < 60 bpm at visit 1
- •history of hypersensivity to any of the drugs investigated as well as known or
- •suspected contraindications to the study drug of previous history of
- •intolerance to high dose of RAAS antagonists or beta-blocker in the absence of
- •any other bloddpressure lowering drugs
- •Creatinin > 2.5 mg/dl
研究者
相似试验
进行中（未招募）
1 期
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-NLMedizinische Universität Wien2,400
进行中（未招募）
1 期
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-ATMedizinische Universität Wien2,400
进行中（未招募）
1 期
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-ESMedizinische Universität Wien2,400
进行中（未招募）
1 期
A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease.EUCTR2015-000239-34-GBMedical University of Vienna2,400
已完成
不适用
The BNP Assisted Teatment to Lessen Serial Cardiac Readmissions and Death.Cardiovascular - Other cardiovascular diseasesHeart FailureACTRN12605000735651Health Research Council of New Zealand363